PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 6203365-6 1984 The findings strongly suggest a non-cytotoxic secretory process requiring the presence of two quaternary ammonium groups as suggested by the rarity of release with tubocurarine; inhibition of succinyldicholine (suxamethonium)-induced histamine release by serum cholinesterase treatment, acetylcholine and tubocurarine; and the bell-shaped dose-response curve, particularly with suxamethonium. quaternary ammonium 94-113 butyrylcholinesterase Homo sapiens 261-275 14331249-0 1965 [PROTECTION EXERCISED BY CHOLINESTERASE INHIBITORS WITH 1 OR 2 QUATERNARY AMMONIUM FUNCTIONS AGAINST THE INHIBITORY CAPACITY OF PROSTIGMINE]. quaternary ammonium 63-82 butyrylcholinesterase Homo sapiens 25-39 9671522-0 1998 Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF. quaternary ammonium 37-56 butyrylcholinesterase Homo sapiens 82-103 9671522-9 1998 This labeling study establishes the existence of two different binding domains for quaternary ammonium in BuChE and exemplifies additional cation/pi interactions in cholinergic proteins. quaternary ammonium 83-102 butyrylcholinesterase Homo sapiens 106-111